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The relationship between physical activity
and lymphoma: a systematic review and
meta analysis
Gwynivere A. Davies1* , Christopher Strader2, Richa Chibbar3, Stefania Papatheodorou4 and Adam A. Dmytriw5
Abstract
Background: The literature suggests an increased risk between anthropometrics including higher body mass
index and lymphoma incidence; however, the association with physical activity remains unclear. A systematic
review/meta-analysis was therefore performed to examine this association with physical activity (total,
recreational or occupational).
Methods: PubMed, Web of Science and Embase were reviewed from inception to October 2019 identifying
relevant observational studies. Non-Hodgkin lymphoma (NHL) including subtypes diffuse large B cell
lymphoma, follicular lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma, and Hodgkin
lymphoma (HL) were analyzed. Included studies reported activity, lymphoma cases, effect size and variability
measures, and were restricted to human subjects of any age. Data was pooled generating summary relative
risk (RR) estimates with 95% confidence intervals (CI) using random-effects models with primary outcome of
histologically confirmed incident lymphoma.
Results: One thousand four hundred studies were initially identified with 18 studies (nine cohort, nine case-
control) included in final analysis. Comparing highest vs. lowest activity categories was protective for all
lymphoma (RR 0.89, 95%CI 0.81–0.98). Sensitivity analysis demonstrated effect persistence within case-control
studies (RR 0.82, 95% CI 0.71–0.96), but not cohort studies (RR 0.95, 95%CI 0.84–1.07). Borderline protective
effect was seen for NHL (RR 0.92, 95%CI 0.84–1.00), but not HL (RR 0.72, 95%CI 0.50–1.04). Analysis by NHL
subtype or gender showed no effect. Dose response analysis demonstrated a protective effect (p = 0.034)
with a 1% risk reduction per 3 MET hours/week (RR 0.99, 95%CI 0.98–1.00).
Conclusions: Physical activity may have a protective effect against lymphoma development; further studies
are required to generate recommendations regarding health policy.
Trial registration: This study was registered prospectively at PROSPERO: CRD42020156242.
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Background
Lymphoma is a common malignancy, with non-Hodgkin
lymphoma (NHL) incidence estimated at 19.6 per 100,
000 people per year and a lifetime risk of 2.2% [1, 2]. By
comparison, Hodgkin lymphoma (HL) is much less com-
mon with only 8110 new cases and 1000 deaths per year.
The incidence for both types has been decreasing over
the past decade, with a drop of 0.9 and 1.8% yearly for
NHL and HL respectively [3]. While a reassuring trend,
up to one-third of patients will still die from NHL within
the first 5 years (5-year survival 72%) [4].
In addition to new oncologic therapies, further research
is needed to direct disease prevention, specifically modifi-
able risk factors, such as physical activity. Prior meta-
analyses demonstrated a relationship between obesity and
lymphoma incidence in a dose-dependent manner (obesity
vs. overweight vs. normal weight) [5–7]; however, it re-
mains unclear if there is an association between physical
activity and lymphoma independent of body mass index
(BMI) [8]. Additionally, BMI does not always reflect obes-
ity or inactivity, therefore an alternate metric was consid-
ered. Studies have shown a reduction in the risk of
development of colon, breast, and endometrial cancer
with physical activity [9], whereas various studies in lung,
prostate and ovarian cancer have been inconclusive [10].
Better understanding of the available evidence for lymph-
oma could inform discussions with patients and better
guide health policy recommendations.
Compared to the costs of treatment [11], physical ac-
tivity is not only cost-effective [12] but is also associated
with increased life expectancy and additional health ben-
efits, including reductions in heart disease, hypertension,
and diabetes [13]. Unfortunately, adherence to weight
loss strategies and caloric restriction is low [13]. There-
fore, a demonstrated protective effect against lymphoma
and other cancers, independent of weight loss or normal
range BMI, could lead to a focus in public health policy
on physical activity with downstream effects on overall
incidence and survival. This could additionally result in
positive health system economic impacts.
This meta-analysis expands on prior work [5, 10, 14]
by incorporating two case-control [15, 16] and two co-
hort studies [17, 18] with 1432 additional lymphoma
cases that have since been published, increasing case
sample size by approximately 12%. In addition, within
previous efforts [10] the outcome key words of “(lymph-
oma OR Hodgkin)” were likely satisfactory, however the
exposure keywords may have missed studies examining
specific forms of activity leading to incomplete evalu-
ation which require further examination in subgroup or
sensitivity analyses. Lastly, while the effect size in the
original meta-analysis suggested a nonsignificant pro-
tective effect (pooled odds ratio (OR) = 0.90, 95% confi-
dence interval (CI): 0.79–1.02, p = 0.10) [10], the limited
number of studies may have precluded definitive assess-
ment because of inadequate power. A latter analyses
demonstrated a protective effect [14], although serious
methodological concerns exist regarding subjects being
included multiple times to account for different forms of
activity (occupational and recreational) within the same
analysis.
The objective of this meta-analysis is to examine all
existing evidence to determine if physical activity leads
to a lower risk for developing lymphoma.
Methods
Literature search
Cohort and case-control studies that reported the level
or amount of physical activity, either recreational, occu-
pational or total, and incidence of lymphoma develop-
ment were identified using Medline, Embase and Web of
Science using the search terms included in Supplemen-
tary Table 1 on October 28, 2019. An updated search
was completed on August 2, 2020, which is reflected in
the included manuscript and figures. Abstracts were
screened by two researchers (two groups- G.D. and A.D,
C.S and R.C.) working independently to select for full-
text reading. In case of disagreement, discussion with all
screening researchers ensued until consensus was
reached. No restrictions on publication date were ap-
plied. Subsequently, two researchers (same groups) inde-
pendently performed full-text reading of each article for
final selection. Additionally, bibliographies of articles se-
lected for full text review were examined for further
studies to include.
Study selection and assessment of quality
Articles were considered eligible if they contained ori-
ginal data on physical activity and risk of lymphoma.
Overall or all lymphoma included patients with both
NHL and HL; further subgroup analyses was performed
as detailed below and according to NHL subtype. Studies
were reviewed to ensure no duplication of included pa-
tients. If multiple publications utilizing the same popula-
tion were identified, the most recent and more detailed
article was included. The nine-star Newcastle-Ottawa
scale (NOS) was used to assess for quality given the ob-
servational nature of cohort and case-control studies.
G.D. and A.D. independently assessed study quality and
group discussion was utilized to resolve disagreements.
Data extraction
General study characteristics (such as author name, year
of publication, number of patients and years of follow up
(cohort) or number of cases and controls (case-control))
were collected along with subject characteristics and ac-
tivity level exposure. Lymphoma was commonly identi-
fied through cancer registry linkage, though some
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studies performed histologic review. As with previous
analyses of physical activity and risk for lymphoma, the
effect estimate used for pooled analysis compared the
highest to lowest or referent physical activity level [10,
14]. In studies presenting multiple models including la-
tency adjustment, only the risk and variability estimate
from the maximally adjusted model were included.
Statistical analyses
Analysis was first conducted including patients from all
studies, with risk estimates selected according to the
most representative form of physical activity (total, rec-
reational or if neither was available, occupational activ-
ity). Relative risk (RR) was chosen as the common
measure; hazard ratios (HR) and OR were considered as
RR due to the low incidence of lymphoma. Summary es-
timation of risk was derived by random effects models
with associated 95% CI. Estimates were then pooled ac-
cording to pre-specified subgroups, including: NHL vs.
HL, type of physical activity (occupational vs. recre-
ational), gender, and lymphoma subtype including fol-
licular lymphoma (FL), diffuse large B cell lymphoma
(DLBCL), and chronic lymphocytic leukemia/small
lymphocytic lymphoma (CLL/SLL). Planned subgroup
analysis that could not be completed included exposure
reporting (self-reported vs. recorded) due to a lack of
studies utilizing the latter method, location due to lim-
ited studies outside of North America, and age as this
was generally included as a covariate. Study heterogen-
eity was analyzed using the Cochrane’s Q test and the I2
statistic utilizing the following cut-offs: < 25% (low het-
erogeneity), 25–50% (moderate heterogeneity), > 50%
(high heterogeneity). Begg’s rank correlation and Egger’s
linear regression tests were used to examine for publica-
tion bias. Cumulative meta analysis assessed for change
in effect size with time, especially as case definitions
changed. Meta regression influence analysis was per-
formed to assess for single study effects. Prediction in-
tervals, demonstrating plausible ranges for the effect size
in future studies, are included in Forest plots.
Dose response analysis utilized studies that reported
metabolic equivalent of task (MET) hours/week of recre-
ational physical activity (seven studies- four cohort, three
case control). In studies where men and women were re-
ported only separately, these were included as unique es-
timates. Midpoints of each range were used as the
Fig. 1 PRISMA flow diagram
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corresponding “dose” and open ended categories utilized
the lower end of the range multiplied by 1.2 as has been
previously suggested [19, 20]. Planned analyses were
submitted to PROSPERO prior to data extraction. PRIS
MA Checklist was followed and completed. All statistical
analyses were performed using Stata version 15.1
(STATA Corp, College Station, TX, USA). p values were
two sided, and level of significance was set at < 0.05.
Results
Literature search and study characteristics
Using our search strategy, 1400 potentially relevant stud-
ies were identified after removal of duplicates. After title
and abstract screening, 113 studies were identified for
full text review including those identified on review of
prior meta-analyses [10, 14, 21]. Final analysis included
18 studies- 9 cohort [17, 18, 22–28] and 9 case-control
[15, 16, 29–35], reporting a total of 12,053 new lymph-
oma cases. Study characteristics are summarized in
Table 1. The PRISMA flowchart detailing study review is
presented in Fig. 1; the most common reasons for exclu-
sion were lack of physical activity information (n = 33),
review or commentary (n = 16), not relevant (n = 12, ie.
physical activity levels after diagnosis of lymphoma), du-
plicate (n = 11), meta-analyses (n = 8), etc. Initially, the
InterLymph studies were included, comprising a multi-
national consortium of NHL cases from 19 case-control
studies presented as patient level data, however on close
review of the datasets there was significant concern for
patient overlap so they were excluded [36–39]. Add-
itional review identified the Physical Activity Collabor-
ation of the National Cancer Institute’s Cohort
Consortium, which pooled data from 12 prospective co-
hort studies comprising 1.44 million participants [40].
This evaluated leisure time physical activity and risk for
cancer development in cohorts not specifically examin-
ing lymphoma development, identifying 6953 incident
cases of NHL. However, four of these cohorts have
already been included in our initial meta-analysis (ac-
counting for 5643 cases); inclusion of risk estimates
from the remaining cohorts (1310 new cases of NHL)
did not change our risk estimate (RR 0.90 (0.83–0.98))
and as we were unable to assess quality of individual
studies, these numbers/cohorts were not included in our
final analysis. The overall pooled HR 0.91 (0.83–1.00) is
reassuringly similar to our identified risk estimate.
Publication years ranged from 1991 to 2018, and most
studies were conducted in North America, with the ex-
ception of Pukkala et al. (2000) and van Veldhoven et al.
(2011) [26, 28] conducted in Finland and multiple Euro-
pean countries respectively. Four studies reported only
effect sizes for women [22, 23, 25, 31], three for men
[26, 29, 34], and three studies only presented both gen-
ders separately [27, 33, 35]. The remaining studies
Table 2 Quality assessment of included studies
Study Selection Comparability Outcome or Exposure Total Risk of Bias
Cohort Studies
Barberio et al., 2018 [17] *** ** ** 7 Low
Cerhan et al., 2002 [22] *** * ** 6 Moderate
Kabat et al., 2012 [23] *** ** *** 8 Low
Lim et al., 2007 [24] *** ** *** 8 Low
Lu et al., 2009 [25] ** * ** 5 Moderate
Pukkala et al., 2000 [26] * ** 3 High
Teras et al., 2012 [27] *** ** *** 8 Low
van Veldhoven et al., 2011 [28] ** * * 4 Moderate
Walter et al., 2013 [18] *** ** *** 8 Low
Case-Control Studies
Boyle et al., 2015 [15] *** ** * 6 Moderate
Brownson et al., 1991 [29] * * * 3 High
Cerhan et al., 2005 [30] ** ** * 5 Moderate
Etter et al., 2018 [16] * ** ** 5 Moderate
Keegan et al., 2006 [31] **** ** * 7 Low
Kelly et al., 2012 [32] ** ** 4 Moderate
Pan et al., 2005 [33] **** ** ** 8 Low
Parent et al., 2011 [34] ** ** * 5 Moderate
Zahm et al., 1999 [35] *** * * 5 Moderate
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reported effect estimates for men and women combined
+/− separately. Participants ranged from 19 to 84 years
of age. Exposure (ie. type, intensity and frequency of ac-
tivity) was most commonly self- reported by question-
naire, followed by phone and in person interview.
Activity period ranged from “current” to lifetime, and
four studies reported multiple types of physical activity
(total, recreational or occupational) [17, 27, 28, 30].
There was wide variation in physical activity type (total,
occupational, recreational) and reporting of activity level
(days per week, percentage of time spent on strenuous
activity, MET hours per week, etc).
Given the time periods included there were multiple
lymphoma classification systems used. For instance, CLL
was considered leukemia in the earlier studies, however
was later combined with SLL under NHL in a WHO up-
date, thus potentially biasing against an effect (less
“lymphoma” cases in the initial studies). Adjustment for
confounders varied widely across studies, with most
adjusting for age, gender, and several for BMI, other
types of activity, or other anthropometric measures.
Studies ranged from high risk (three stars) to low risk of
bias (eight stars), with the majority of case-control and
cohort studies being of moderate (6/9) and low risk (5/
9) of bias, respectively (Table 2).
New cases of NHL and HL combined (“all lymphoma”)
In total, 3009 new cases of lymphoma were diagnosed
within the highest physical activity level. This yielded 27
estimates comparing the highest to lowest level of phys-
ical activity, yielding a protective summary RR of 0.89
(95% CI 0.81–0.98) (Fig. 2). The Q statistic indicates
moderate heterogeneity of study results (chi2 = 49.39;
I2 = 47.4%, p = 0.004). Use of Egger’s test demonstrates
Fig. 2 Risk for all lymphoma comparing the highest versus lowest level of physical activity. ES = Effect size
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no small study effects (p = 0.29) and influence analysis
excluding one study at a time shows slight variation in
effect size, but this does not change by more than 2%.
The confidence intervals do not include 1 with exclusion
of any studies. Sensitivity analysis utilizing cumulative
meta-analysis demonstrates stabilization of effect size
around 2009.
Sensitivity analysis by study type
Sensitivity analysis was performed by analyzing cohort
and case-control studies separately assessing “all lymph-
oma”. Among the nine cohort studies, 13 effect esti-
mates were included as two studies described effect
estimates separately by gender only and one study in-
cluded both NHL and HL separately. The summary RR
was not significant at 0.95 (95% CI 0.84–1.07; I2 = 39.9%,
p = 0.07). By comparison, among the nine case-control
studies, there were 14 effect estimates (both NHL and
HL estimates from two studies, two studies with genders
reported separately and one study with two individual
age groups), and demonstrated significant protection
with higher levels of exercise at RR 0.82 (95% CI 0.71–
0.96; I2 = 49.5%, p = 0.02).
Subgroup analysis
Seventeen of 18 studies examined the risk for NHL de-
velopment in relation to physical activity. Pooling of ef-
fect size showed a marginally significant protective effect
between the highest and lowest levels of physical activity
(RR 0.92, 95% CI 0.84–1.00, I2 = 42.3%, p = 0.02) seen in
Fig. 3. No benefit was found in males with NHL (RR
1.02, 95% CI 0.90–1.15; I2 = 5.2%, p = 0.39), while in fe-
males there was a non-significant trend towards benefit
(RR 0.88, 95% CI 0.72–1.08; I2 = 66.2%, p = 0.003).
Fig. 3 Risk for non-Hodgkin lymphoma comparing the highest versus lowest level of physical activity. ES = Effect size
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Interestingly, utilizing sex specific risk estimates signifi-
cantly reduced between study heterogeneity as demon-
strated by Cochrane’s Q test (chi2 8.44) and I2 for
men (see previous), but did not reduce heterogeneity
for women, potentially suggesting differences in popu-
lation selection.
Subgroup analysis by NHL subtypes of DLBCL, FL
and CLL/SLL was performed to assess for biological
heterogeneity in response to physical activity. In studies
reporting DLBCL incidence, no difference in risk was
found (RR 0.95, 95% CI 0.83–1.09; I2 = 0%, p = 0.44).
This was consistent when restricting to estimates in men
(RR 1.27, 95% CI 0.71–2.27; I2 = 0%, p = 0.56) or women
(RR 0.97, 95% CI 0.76–1.25; I2 = 28.6%, p = 0.22).
Among those studies examining FL, no protective ef-
fect was found with physical activity (RR 0.95, 95% CI
0.80–1.12; I2 = 10.4%, p = 0.34) in both genders, or when
limited to men (RR 0.96, 95% CI 0.65–1.43; I2 = 0%, p =
0.42) or women (RR 0.97, 95% CI 0.75–1.26; I2 = 9.3%,
p = 0.36) though sex stratified estimates were limited to
only three and five studies, respectively.
Lastly, in studies assessing CLL/SLL incidence, there
was no benefit between the highest and lowest levels of
physical activity (RR 0.95, 95% CI 0.76–1.20; I2 = 43.6%,
p = 0.07), or according to sex specific estimates for men
(RR 1.18, 95% CI 0.73–1.91; I2 = 49.9%, p = 0.14) or
women (RR 1.07, 95% CI 0.65–1.74; I2 = 70.1%, p =
0.010, suggesting high heterogeneity).
In total, five studies reported HL incidence yielding six
effect estimates (one study reported estimates for two
separate age groups). There was a trend towards protect-
ive benefit comparing highest and lowest levels of phys-
ical activity (RR 0.72, 95% CI 0.50–1.04; I2 = 42.3%, p =
0.12) that was not significant (Fig. 4). A significant bene-
fit was found in women (RR 0.55, 95% CI 0.39–0.80;
I2 = 0%, p = 0.60), but not men (RR 1.05, 95% CI 0.54–
2.04; I2 = 0%, p = 0.69).
Subgroup analysis of recreational versus occupational
activity demonstrated a protective summary value (RR
0.85, 95% CI 0.76–0.96; I2 = 53.3%, p = 0.002, high het-
erogeneity) for recreational PA; however, this was not
seen for occupational activity (RR 0.93, 95% CI 0.76–
1.14, I2 = 0%, p = 0.75). Total activity level was not ana-
lyzed separately as this is generally a composite of the
prior two measures.
Dose response analysis
Exploratory dose response analysis was performed utiliz-
ing the seven studies which reported MET hours/week
of recreational physical activity and effect estimates.
Most studies reported tertiles or quartiles of physical ac-
tivity, and upper levels ranged from > 4.8 MET hours/
week to ≥45.75 MET hours/week, highlighting the
differences in activity capture and populations. Dose re-
sponse comprised 6019 newly diagnosed lymphoma
cases and demonstrated a significant protective effect
(p = 0.03, Fig. 5), estimated as a 1% reduction in lymph-
oma incidence per 3 MET hours/week of activity (RR
0.99, 95% CI 0.98–1.00; I2 = 61.4%, p = 0.0003).
Discussion
The aim of the current meta-analysis was to present an
updated review of the literature on the association be-
tween physical activity and risk of lymphoma, and to ad-
dress limitations of previous meta-analyses.
We demonstrate that high physical activity levels have a
significant protective effect for the overall risk of lymph-
oma development, borderline protective effect for NHL,
and no effect on HL incidence in both genders combined,
though women alone had a reduced risk of lymphoma
within the highest level of physical activity. This effect es-
timate is consistent with previous studies by Vermaete
et al. (2013) demonstrating a pooled RR of 0.90 (95% CI
0.79–1.02) and Jochem et al. (2014) with a significant
pooled RR of 0.90 (95% CI 0.81–0.99) for lymphoma de-
velopment [10, 14]. This suggests stabilization of effect
with time as multiple newer studies were included in this
updated analysis. Physical activity is postulated to reduce
risk of other malignancies [41–44] through a variety of
mechanisms that may be relevant to clonal lymphocyte
dysregulation. These can include: epigenetic modification,
such as via restoration of normal methylation status or
upregulation of p53 proteins [45]; improved insulin sensi-
tivity with resistance identified as a mediator between in-
creased height or weight and lymphoma risk [21];
reduction of inflammatory cytokines via obesity reduction
and lower levels of the ASC protein [45]; and various
other biologic etiologies.
Sensitivity analysis demonstrated a non-significant effect
in cohort studies, which would have a lower risk of bias
due to their prospective design. This is relevant for phys-
ical activity, as there is potential for recall bias in self-
reported recreational exercise, especially when considering
lifetime values. However, this may be less relevant for oc-
cupational activity which was usually expertly coded ac-
cording to an occupation algorithm. Another potential
source of bias is reverse causation whereby those report-
ing lower baseline activity may paradoxically have an un-
diagnosed cancer. Multiple cohorts addressed this by
performing “latency adjusted” analysis, in which cases di-
agnosed within the first 2 years of study were excluded
without significant change in their estimates [17, 23, 25].
No noticeable difference in effect size was seen by NHL
subtype, and the small number of further gender stratified
studies limits specific conclusions. Several studies reported
effect estimates for other NHL subtypes, such as mycosis
fungoides/Sezary syndrome, marginal zone lymphoma,
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peripheral T cell lymphoma, and lymphoplasmacytic lymph-
oma/Waldenstrom macroglobulinemia, but were too infre-
quent to synthesize. The latency of lymphoma may be
important to consider when deciding on relevant time period
of activity. For example, recent BMI has significantly more
impact on DLBCL than FL or CLL/SLL [21], which may re-
late to the longer period of development for indolent lymph-
omas. Analogously, lifelong activity may be more relevant to
these lymphomas, whereas recent activity may have a stron-
ger impact on aggressive lymphoma subtypes. This could be
Fig. 4 Risk for Hodgkin lymphoma comparing the highest versus lowest level of physical activity. ES = Effect size
Fig. 5 Exploratory dose response analysis for studies reporting recreational physical activity in metabolic equivalent of task (MET) hours per week
(a), and Forest plot demonstrating summary reduced relative risk per 3 MET hours per week (b)
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explored in future studies comparing lifelong and recent ac-
tivity to NHL subtype incidence.
In examining gender modification, we included only
studies that reported effect estimates for men or
women alone. No protective effect of physical activity
was seen for men, however in women there was re-
duced risk for HL and a protective trend for NHL.
The biologic mechanisms for this effect are not fully
understood, however most lymphomas are more com-
mon in males, thus development may be more heavily
influenced by other biologic factors within this gender
[37]. Previous authors have suggested this may also
be due to estrogen or reproductive effects [14]- po-
tentially by reducing body fat and thus the location of
conversion from androstenedione to estrogen or by
increasing levels of sex hormone binding globulin [6],
which may affect inflammatory cytokine production.
These results should be interpreted with caution,
given the limited number of studies with sex stratifi-
cation, although this was frequently controlled for in
multivariable risk analysis.
Biologic plausibility is supported by the findings of re-
duced risk for lymphoma development by increasing
MET hours/week of recreational physical activity. This
occurred linearly with a reduction of 1% per 3 MET
hours/week, equivalent to 1 hour of walking at average
pace. Dose response has been demonstrated in other
malignancies such as breast cancer [46] and represents
an important step towards developing guidelines for ac-
tivity. The World Health Organization recommends 150
min of moderate (3–6 MET/hour) level physical activity
per week for adults, which translates to an average of
11.25 additional MET hours in addition to daily activ-
ities [47]. Using our estimated reduction of 1% per 3
MET hours/week, this could result in a relative 3.75%
fewer cases of lymphoma with guideline adherence.
Several limitations deserve discussion, primarily the
heterogeneity in physical activity reporting. Some studies
consider total activity, combining occupational, recre-
ational and occasionally household activities, while
others report only occupational or recreational activity,
with widely discrepant referent and “highest level” of
physical activity. As described previously, the upper
quartile of MET hours/week of physical activity could
vary by up to 10 between studies, ranging from > 4.8
[18] to ≥45 [32]. Ideally, patient level data would be
accessed such that risk could be considered continuously
rather than by quartile, however this is impractical given
how initial data were collected (written questionnaire,
etc) especially given variation in activity “units”. Consid-
erations for future analysis include collapsing all levels
of physical activity for comparison to basal inactivity,
similar to a meta-analysis examining cancer risk related
to pickled vegetable consumption [48].
Additionally, the timing of activity varied greatly with
studies reporting “baseline” activity at enrollment, per-
sonal quantification of lifetime activity, specific age ac-
tivity, and so on. Given the overall incidence of
lymphoma and non-compliance inherent to activity in-
terventions [13], a randomized study examining this as-
sociation is impractical; thus, health care policy
recommendations will undoubtedly rely on observational
studies. Standardization of timing, type and intensity of
physical activity within future cohort studies is therefore
imperative.
A further weakness includes the type and number of
confounders adjusted for. While most studies adjusted
for age, the number of included covariates ranged from
zero to 12, demonstrating the wide variance in suspected
etiologic triggers which was corroborated by the Inter-
Lymph consortium [37]. A recent meta-analysis demon-
strated a positive association of early adult BMI and
weight with NHL risk [21], and the complex interplay
between BMI and physical activity was not consistently
captured. Control selection in case-control studies is of
particular importance, and one study utilized male pa-
tients with other cancers which could bias towards the
null [29]. Gender stratified analyses were limited, espe-
cially for NHL subtypes and preclude definitive conclu-
sions. Additionally, definitions of lymphoma have
significantly changed in the past two decades with intro-
duction of the WHO classification in the early 2000s,
and therefore there is likely misclassification in older
studies.
Conclusions
Overall, the highest level of physical activity appears
to be protective against lymphoma development, com-
pared to the lowest level. While this association is
most apparent for NHL, a paucity of studies have
assessed HL outcomes likely due to the lower inci-
dence of this malignancy, and thus conclusions are
limited. Female subjects appear to benefit from higher
levels of activity however the limited number of gen-
der stratified results preclude sex specific conclusions.
Dose response analysis supports these conclusions,
with a linear decrease in incidence seen with increas-
ing recreational physical activity. This is especially
relevant as recreational activity is more modifiable
than occupation associated activity. Our study repre-
sents a comprehensive review of current literature
without significant methodological concerns seen in
previous analyses examining this relationship. Further
higher quality cohorts, controlling for both anthropo-
metric and cancer risk factors and with standardized
activity reporting are needed to reach definitive con-
clusions and develop policy recommendations.
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